Press Releases

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Jan 12, 2026

Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

Dec 17, 2025

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

Dec 3, 2025

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Nov 4, 2025

Axogen, Inc. Reports Third Quarter 2025 Financial Results

Oct 29, 2025

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

Oct 15, 2025

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Aug 27, 2025

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft

Aug 25, 2025

Axogen, Inc. Reports Second Quarter 2025 Financial Results

Aug 5, 2025

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025